Aarey Drugs & Pharmaceuticals Limited

AAREYDRUGS

Quarterly results

standalone

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 202645

    Quarter₹ croreYoY
    Jun 2024127+149.1%
    Sept 2024105+81.8%
    Dec 2024134+74.9%
    Mar 2025108-48.6%
    Jun 2025102-19.5%
    Sept 202584-20.0%
    Dec 202596-27.9%
    Mar 2026189+75.3%
    Jun 202645-56.3%
  • ₹ crore

    Jun 20262

    Quarter₹ crore
    Jun 20242
    Sept 20240.02
    Dec 20240.68
    Mar 20258
    Jun 20252
    Sept 20250.79
    Dec 20254
    Mar 2026-0.43
    Jun 20262
  • ₹ crore

    Jun 202646

    Quarter₹ crore
    Jun 2024128
    Sept 2024105
    Dec 2024134
    Mar 2025116
    Jun 2025104
    Sept 202585
    Dec 2025101
    Mar 2026189
    Jun 202646
  • Cost structure
  • ₹ crore

    Jun 20260.16

    Quarter₹ crore
    Jun 20240.14
    Sept 20240.22
    Dec 20240.18
    Mar 20250.27
    Jun 20250.14
    Sept 20250.19
    Dec 20250.15
    Mar 20260.29
    Jun 20260.16
  • ₹ crore

    Jun 202646

    Quarter₹ crore
    Jun 2024127
    Sept 2024103
    Dec 2024133
    Mar 2025114
    Jun 2025102
    Sept 202583
    Dec 2025100
    Mar 2026188
    Jun 202646
  • Exceptional items and tax
  • ₹ crore

    Jun 20260.52

    Quarter₹ crore
    Jun 20241
    Sept 20242
    Dec 20241
    Mar 20252
    Jun 20252
    Sept 20251
    Dec 20250.92
    Mar 20261
    Jun 20260.52
  • ₹ crore

    Jun 2026-0.51

    Quarter₹ crore
    Jun 20240.09
    Sept 20240.15
    Dec 20240.68
    Mar 20251
    Jun 20250.36
    Sept 20250.46
    Dec 20250.35
    Mar 2026-0.28
    Jun 2026-0.51
  • Profit
  • ₹ crore

    Jun 20261

    Quarter₹ croreYoY
    Jun 20241+71.0%
    Sept 20242+103.5%
    Dec 20240.72-29.8%
    Mar 20250.47-78.2%
    Jun 20251+10.7%
    Sept 20251-35.9%
    Dec 20250.57-20.7%
    Mar 20262+231.3%
    Jun 20261-25.4%
  • Per share
  • ₹ per share

    Jun 20260.36

    Quarter₹ per share
    Jun 20240.88
    Sept 20241.14
    Dec 20240.26
    Mar 20250.04
    Jun 20250.48
    Sept 20250.72
    Dec 20250.20
    Mar 20260.55
    Jun 20260.36
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
127105134108102849618945
Revenue YoY+149.1%+81.8%+74.9%-48.6%-19.5%-20.0%-27.9%+75.3%-56.3%
20.020.68820.794-0.432
1281051341161048510118946
Cost structure
0.140.220.180.270.140.190.150.290.16
1271031331141028310018846
Exceptional items and tax
1212210.9210.52
0.090.150.6810.360.460.35-0.28-0.51
Profit
120.720.47110.5721
Net profit YoY+71.0%+103.5%-29.8%-78.2%+10.7%-35.9%-20.7%+231.3%-25.4%
Per share
0.881.140.260.040.480.720.200.550.36

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.